Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 210 |
| Gross Profit | N/A | N/A | N/A | 210 |
| Operating Expenses | 68,610 | 37,809 | 29,192 | 12,266 |
| Operating Income | -68,610 | -37,809 | -29,192 | -12,056 |
| Interest Expense | 1,375 | 1,370 | 0 | 0 |
| Other Income | 8,554 | 2,874 | 1,482 | 2,869 |
| Pre-tax Income | -61,431 | -36,305 | -27,710 | -9,187 |
| Net Income Continuous | -61,431 | -36,305 | -27,710 | -9,187 |
| Net Income | $-61,431 | $-36,305 | $-27,710 | $-9,187 |
| EPS Basic Total Ops | -2.50 | -9.73 | -8.04 | -3.81 |
| EPS Basic Continuous Ops | -2.50 | -9.73 | -8.04 | -3.81 |
| EPS Diluted Total Ops | -2.50 | -9.73 | -8.04 | -3.81 |
| EPS Diluted Continuous Ops | -2.50 | -9.73 | -8.04 | -3.81 |
| EPS Diluted Before Non-Recurring Items | -2.50 | -9.73 | -8.04 | N/A |
| EBITDA(a) | $-68,108 | $-37,436 | $-28,850 | $-11,911 |